About Thomas Hecht
Form D filings for Encentrio Therapeutics in 2023 list Thomas Hecht as director.
Thomas Hecht first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Hecht in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Thomas Hecht works with at each company, as listed on that company's latest Form D.
Encentrio Therapeutics, Inc. · Form D, Apr 3, 2023
GS
George Scangos
Director
SL
Sung Lee
Executive officer and director
JN
Johanna Friedl-Naderer
Director
NS
Natascha Schill
Chief Executive Officer and director
VV
Vanina de Verneuil
Executive officer